Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study
In this real-world Korean study, adding GLP-1RA to BI reduced risks of diabetes complications and all-cause mortality than adding SAI or shifting to premixed insulin.
Authors
- Dae Jung Kim (ORCID: https://orcid.org/0000-0003-1025-2044)
- Kyoung Hwa Ha (ORCID: https://orcid.org/0000-0002-3408-7568)
- Donghan Kim (ORCID: https://orcid.org/0000-0002-0973-8074)
- Won–Ho Kim (ORCID: https://orcid.org/0000-0002-4849-472X)
Institutions
- Sanofi (South Korea) (KR)
- Ajou University (KR)
Publication Details
- Journal
- Journal of Diabetes and its Complications
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.jdiacomp.2025.108983
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00